Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Edward Gardner to HIV Infections

This is a "connection" page, showing publications Edward Gardner has written about HIV Infections.

 
Connection Strength
  
 
 
3.619
  
  1. Hawkins KL, Hojat LS, Hicks C, McLees MP, Rowan S, Burman WJ, Gardner EM. The "ART review": formalizing a process to document complex HIV treatment histories and to support treatment optimization. AIDS Care. 2025 Nov; 37(11):1883-1893.
    View in: PubMed
    Score: 0.311
  2. Gardner EM, Hawkins KL. Same-day Start of Antiretroviral Therapy Demonstrates the Potential To Lessen Disparities in Human Immunodeficiency Virus Treatment Outcomes. Clin Infect Dis. 2021 07 01; 73(1):e129-e131.
    View in: PubMed
    Score: 0.231
  3. Hawkins KL, Montague BT, Rowan SE, Beum R, McLees MP, Johnson S, Gardner EM. Boosted darunavir and dolutegravir dual therapy among a cohort of highly treatment-experienced individuals. Antivir Ther. 2019; 24(7):513-519.
    View in: PubMed
    Score: 0.195
  4. Gardner EM, Haukoos JS. At the Crossroads of the HIV Care Continuum: Emergency Departments and the HIV Epidemic. Ann Emerg Med. 2015 Jul; 66(1):79-81.
    View in: PubMed
    Score: 0.151
  5. Rowan SE, Burman WJ, Johnson SC, Connick E, Reirden D, Daniloff E, Gardner EM. Engagement-in-care during the first 5 years after HIV diagnosis: data from a cohort of newly HIV-diagnosed individuals in a large US city. AIDS Patient Care STDS. 2014 Sep; 28(9):475-82.
    View in: PubMed
    Score: 0.143
  6. Gardner EM, Young B. The HIV care cascade through time. Lancet Infect Dis. 2014 Jan; 14(1):5-6.
    View in: PubMed
    Score: 0.135
  7. Gardner EM, Daniloff E, Thrun MW, Reirden DH, Davidson AJ, Johnson SC, Wilmoth R, Connick E, Burman WJ. Initial linkage and subsequent retention in HIV care for a newly diagnosed HIV-infected cohort in Denver, Colorado. J Int Assoc Provid AIDS Care. 2013 Nov-Dec; 12(6):384-90.
    View in: PubMed
    Score: 0.134
  8. Gardner EM, Melendez AG, Astiz M, Bray K. Adherence and preexisting major protease inhibitor resistance mutations are associated with virologic failure of a dual-class antiretroviral regimen with inhibitors of HIV-1 viral protease and integrase. J Int Assoc Physicians AIDS Care (Chic). 2012 Jan-Feb; 11(1):34-9.
    View in: PubMed
    Score: 0.118
  9. Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011 Mar 15; 52(6):793-800.
    View in: PubMed
    Score: 0.113
  10. Gardner EM, Hullsiek KH, Telzak EE, Sharma S, Peng G, Burman WJ, MacArthur RD, Chesney M, Friedland G, Mannheimer SB. Antiretroviral medication adherence and class- specific resistance in a large prospective clinical trial. AIDS. 2010 Jan 28; 24(3):395-403.
    View in: PubMed
    Score: 0.105
  11. Gardner EM, Burman WJ, Steiner JF, Anderson PL, Bangsberg DR. Antiretroviral medication adherence and the development of class-specific antiretroviral resistance. AIDS. 2009 Jun 01; 23(9):1035-46.
    View in: PubMed
    Score: 0.100
  12. Parienti JJ, Bangsberg DR, Verdon R, Gardner EM. Better adherence with once-daily antiretroviral regimens: a meta-analysis. Clin Infect Dis. 2009 Feb 15; 48(4):484-8.
    View in: PubMed
    Score: 0.098
  13. Gardner EM, Sharma S, Peng G, Hullsiek KH, Burman WJ, Macarthur RD, Chesney M, Telzak EE, Friedland G, Mannheimer SB. Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance. AIDS. 2008 Jan 02; 22(1):75-82.
    View in: PubMed
    Score: 0.091
  14. Gardner EM, Maravi ME, Rietmeijer C, Davidson AJ, Burman WJ. The association of adherence to antiretroviral therapy with healthcare utilization and costs for medical care. Appl Health Econ Health Policy. 2008; 6(2-3):145-55.
    View in: PubMed
    Score: 0.091
  15. Gardner EM, Burman WJ, Maravi ME, Davidson AJ. Durability of adherence to antiretroviral therapy on initial and subsequent regimens. AIDS Patient Care STDS. 2006 Sep; 20(9):628-36.
    View in: PubMed
    Score: 0.083
  16. Gardner EM, Burman WJ, Maravi ME, Davidson AJ. Selective drug taking during combination antiretroviral therapy in an unselected clinic population. J Acquir Immune Defic Syndr. 2005 Nov 01; 40(3):294-300.
    View in: PubMed
    Score: 0.078
  17. Hawkins KL, Dandachi D, Verzani Z, Brannock MD, Lewis C, Abedian S, Jaferian S, Wuller S, Truong J, Witvliet MG, Dymond G, Mehta HB, Patel PB, Hill E, Weiner MG, Carton TW, Kaushal R, Feuerriegel E, Tran HG, Marks K, Oliveira CR, Gardner EM, Ofotokun I, Gulick RM, Erlandson KM. HIV Infection and Long COVID: A RECOVER Program, Electronic Health Record-Based Cohort Study. Clin Infect Dis. 2025 10 06; 81(3):427-438.
    View in: PubMed
    Score: 0.078
  18. Gardner EM, Burman WJ, DeGroote MA, Hildred G, Pace NR. Conventional and molecular epidemiology of macrolide resistance among new Mycobacterium avium complex isolates recovered from HIV-infected patients. Clin Infect Dis. 2005 Oct 01; 41(7):1041-4.
    View in: PubMed
    Score: 0.077
  19. Nicholson LK, Kofonow JM, Robertson CE, Wright T, Li Q, Gardner EM, Frank DN, Janoff EN. Clinical and Microbial Determinants of Upper Respiratory Colonization With Streptococcus pneumoniae and Native Microbiota in People With Human Immunodeficiency Virus Type 1 and Control Adults. J Infect Dis. 2024 Dec 16; 230(6):1456-1465.
    View in: PubMed
    Score: 0.074
  20. Kousari AE, Wilson MP, Hawkins KL, Bandali MM, Henao-Martínez AF, Gardner EM, Erlandson KM. Weight change with antiretroviral switch from integrase inhibitor or tenofovir alafenamide-based to Doravirine-Based regimens in people with HIV. HIV Res Clin Pract. 2024 12; 25(1):2339576.
    View in: PubMed
    Score: 0.071
  21. Haukoos J, Hopkins E, Campbell JD, Lyons MS, Rothman RE, Hsieh YH, White DAE, Trent S, Al-Tayyib AA, Gardner EM, Sabel AL, Rowan SE. Cost-Effectiveness of HIV Screening in Emergency Departments: Results From the Pragmatic Randomized HIV Testing Using Enhanced Screening Techniques in Emergency Departments Trial. Ann Emerg Med. 2024 09; 84(3):234-243.
    View in: PubMed
    Score: 0.070
  22. Kamis KF, Barbera L, Abdo M, Rowan SE, Hussain C, Gardner EM, Johnson SC, MaWhinney S, Davis AJ, Carlson J, Kozacka KA, Erlandson KM. Risk Factors for Hospitalization in People With HIV and COVID-19. J Acquir Immune Defic Syndr. 2021 11 01; 88(3):e22.
    View in: PubMed
    Score: 0.059
  23. Haukoos JS, Lyons MS, Rothman RE, White DAE, Hopkins E, Bucossi M, Ruffner AH, Ancona RM, Hsieh YH, Peterson SC, Signer D, Toerper MF, Saheed M, Pfeil SK, Todorovic T, Al-Tayyib AA, Bradley-Springer L, Campbell JD, Gardner EM, Rowan SE, Sabel AL, Thrun MW. Comparison of HIV Screening Strategies in the Emergency Department: A Randomized Clinical Trial. JAMA Netw Open. 2021 07 01; 4(7):e2117763.
    View in: PubMed
    Score: 0.058
  24. Smeaton LM, Kileel EM, Grinsztejn B, Gardner EM, Starr K, Murry ML, Desvigne-Nickens P, Alston-Smith B, Waclawiw MA, Cooper-Arnold K, Madruga JV, Sangle S, Fitch KV, Zanni MV, Douglas PS, Ribaudo HJ, Grinspoon SK, Klingman KL. Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum. J Infect Dis. 2020 07 09; 222(Suppl 1):S31-S40.
    View in: PubMed
    Score: 0.054
  25. Coyle RP, Morrow M, Coleman SS, Gardner EM, Zheng JH, Ellison L, Bushman LR, Kiser JJ, MaWhinney S, Anderson PL, Castillo-Mancilla JR. Factors associated with tenofovir diphosphate concentrations in dried blood spots in persons living with HIV. J Antimicrob Chemother. 2020 06 01; 75(6):1591-1598.
    View in: PubMed
    Score: 0.054
  26. Coyle RP, Schneck CD, Morrow M, Coleman SS, Gardner EM, Zheng JH, Ellison L, Bushman LR, Kiser JJ, Mawhinney S, Anderson PL, Castillo-Mancilla JR. Engagement in Mental Health Care is Associated with Higher Cumulative Drug Exposure and Adherence to Antiretroviral Therapy. AIDS Behav. 2019 Dec; 23(12):3493-3502.
    View in: PubMed
    Score: 0.052
  27. Castillo-Mancilla JR, Coyle RP, Coleman SS, Morrow M, Gardner EM, Zheng JH, Ellison L, Bushman LR, Kiser JJ, MaWhinney S, Anderson PL. Short Communication: Cascade of Antiretroviral Therapy Adherence in Virologically Suppressed Persons Living with HIV. AIDS Res Hum Retroviruses. 2020 03; 36(3):173-175.
    View in: PubMed
    Score: 0.051
  28. Morrow M, MaWhinney S, Coyle RP, Coleman SS, Gardner EM, Zheng JH, Ellison L, Bushman LR, Kiser JJ, Anderson PL, Castillo-Mancilla JR. Predictive Value of Tenofovir Diphosphate in Dried Blood Spots for Future Viremia in Persons Living With HIV. J Infect Dis. 2019 07 19; 220(4):635-642.
    View in: PubMed
    Score: 0.051
  29. Castillo-Mancilla JR, Phillips AN, Neaton JD, Neuhaus J, Sharma S, Baker JV, Collins S, Mannheimer S, Pett S, Touzeau-Römer V, Polizzotto MN, Lundgren JD, Gardner EM. Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study. J Int AIDS Soc. 2019 06; 22(6):e25297.
    View in: PubMed
    Score: 0.050
  30. Castillo-Mancilla JR, Morrow M, Coyle RP, Coleman SS, Gardner EM, Zheng JH, Ellison L, Bushman LR, Kiser JJ, Mawhinney S, Anderson PL. Tenofovir Diphosphate in Dried Blood Spots Is Strongly Associated With Viral Suppression in Individuals With Human Immunodeficiency Virus Infections. Clin Infect Dis. 2019 04 08; 68(8):1335-1342.
    View in: PubMed
    Score: 0.050
  31. Nicholson LK, Pratap H, Bowers E, Gunzburger E, Bandi SR, Gardner EM, Palmer BE, Wright T, Kittelson J, Janoff EN. Effective B cell activation in vitro during viremic HIV-1 infection with surrogate T cell stimulation. Immunobiology. 2018 12; 223(12):839-849.
    View in: PubMed
    Score: 0.048
  32. Anderson PL, Liu AY, Castillo-Mancilla JR, Gardner EM, Seifert SM, McHugh C, Wagner T, Campbell K, Morrow M, Ibrahim M, Buchbinder S, Bushman LR, Kiser JJ, MaWhinney S. Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy. Antimicrob Agents Chemother. 2018 01; 62(1).
    View in: PubMed
    Score: 0.045
  33. Lifson AR, Grund B, Gardner EM, Kaplan R, Denning E, Engen N, Carey CL, Chen F, Dao S, Florence E, Sanz J, Emery S. Improved quality of life with immediate versus deferred initiation of antiretroviral therapy in early asymptomatic HIV infection. AIDS. 2017 04 24; 31(7):953-963.
    View in: PubMed
    Score: 0.043
  34. Castillo-Mancilla J, Seifert S, Campbell K, Coleman S, McAllister K, Zheng JH, Gardner EM, Liu A, Glidden DV, Grant R, Hosek S, Wilson CM, Bushman LR, MaWhinney S, Anderson PL. Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing. Antimicrob Agents Chemother. 2016 11; 60(11):6692-6697.
    View in: PubMed
    Score: 0.042
  35. Castillo-Mancilla JR, Brown TT, Erlandson KM, Palella FJ, Gardner EM, Macatangay BJ, Breen EC, Jacobson LP, Anderson PL, Wada NI. Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression. Clin Infect Dis. 2016 Dec 15; 63(12):1661-1667.
    View in: PubMed
    Score: 0.042
  36. Gardner EM. Improving Retention in HIV Care: A Cost-effective Strategy to Turn the Tide on HIV and AIDS in the United States. Clin Infect Dis. 2016 Jan 15; 62(2):230-2.
    View in: PubMed
    Score: 0.039
  37. Meditz AL, Palmer C, Predhomme J, Searls K, Kerr B, Seifert S, Caraway P, Gardner EM, MaWhinney S, Anderson PL. Relationship Between Genital Drug Concentrations and Cervical Cellular Immune Activation and Reconstitution in HIV-1-Infected Women on a Raltegravir Versus a Boosted Atazanavir Regimen. AIDS Res Hum Retroviruses. 2015 Oct; 31(10):1015-22.
    View in: PubMed
    Score: 0.038
  38. Castillo-Mancilla JR, Searls K, Caraway P, Zheng JH, Gardner EM, Predhomme J, Bushman LR, Anderson PL, Meditz AL. Short communication: Tenofovir diphosphate in dried blood spots as an objective measure of adherence in HIV-infected women. AIDS Res Hum Retroviruses. 2015 Apr; 31(4):428-32.
    View in: PubMed
    Score: 0.037
  39. Seifert SM, Glidden DV, Meditz AL, Castillo-Mancilla JR, Gardner EM, Predhomme JA, Rower C, Klein B, Kerr BJ, Guida LA, Zheng JH, Bushman LR, Anderson PL. Dose response for starting and stopping HIV preexposure prophylaxis for men who have sex with men. Clin Infect Dis. 2015 Mar 01; 60(5):804-10.
    View in: PubMed
    Score: 0.037
  40. O'Connor JL, Gardner EM, Mannheimer SB, Lifson AR, Esser S, Telzak EE, Phillips AN. Factors associated with adherence amongst 5295 people receiving antiretroviral therapy as part of an international trial. J Infect Dis. 2013 Jul; 208(1):40-9.
    View in: PubMed
    Score: 0.032
  41. Rower JE, Meditz A, Gardner EM, Lichtenstein K, Predhomme J, Bushman LR, Klein B, Zheng JH, Mawhinney S, Anderson PL. Effect of HIV-1 infection and sex on the cellular pharmacology of the antiretroviral drugs zidovudine and lamivudine. Antimicrob Agents Chemother. 2012 Jun; 56(6):3011-9.
    View in: PubMed
    Score: 0.030
  42. Nachega JB, Marconi VC, van Zyl GU, Gardner EM, Preiser W, Hong SY, Mills EJ, Gross R. HIV treatment adherence, drug resistance, virologic failure: evolving concepts. Infect Disord Drug Targets. 2011 Apr; 11(2):167-74.
    View in: PubMed
    Score: 0.028
  43. Bryan CL, Beard KS, Pott GB, Rahkola J, Gardner EM, Janoff EN, Shapiro L. HIV infection is associated with reduced serum alpha-1-antitrypsin concentrations. Clin Invest Med. 2010 Dec 01; 33(6):E384-9.
    View in: PubMed
    Score: 0.028
  44. Anderson PL, Kiser JJ, Gardner EM, Rower JE, Meditz A, Grant RM. Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection. J Antimicrob Chemother. 2011 Feb; 66(2):240-50.
    View in: PubMed
    Score: 0.028
  45. Mannheimer SB, Wold N, Gardner EM, Telzak EE, Huppler Hullsiek K, Chesney M, Wu AW, MacArthur RD, Matts J, Friedland G. Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals. Clin Infect Dis. 2008 Mar 15; 46(6):941-5.
    View in: PubMed
    Score: 0.023
  46. Jenkins TC, Gardner EM, Thrun MW, Cohn DL, Burman WJ. Risk-based human immunodeficiency virus (HIV) testing fails to detect the majority of HIV-infected persons in medical care Settings. Sex Transm Dis. 2006 May; 33(5):329-33.
    View in: PubMed
    Score: 0.020
  47. Atkinson TM, Mazumdar M, Van Hyfte G, Lee JY, Li Y, Lynch KA, Webb A, Holland SM, Lubetkin EI, Goldstone S, Einstein MH, Stier EA, Wiley DJ, Mitsuyasu R, Rosa-Cunha I, Aboulafia DM, Dhanireddy S, Schouten JT, Levine R, Gardner EM, Dunlevy H, Barroso LF, Bucher G, Korman J, Stearn B, Wilkin TJ, Ellsworth G, Pugliese JC, Cella D, Berry-Lawhorn JM, Palefsky JM. Health-Related Quality of Life for Persons Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (AMC-A01). JCO Oncol Pract. 2025 Oct; 21(10):1475-1482.
    View in: PubMed
    Score: 0.019
  48. Rowan SE, Rogers M, Bayer J, Smith L, Gardner EM, Johnson S, Langness J. Treatment of Hepatitis C Virus in HIV-Coinfected Individuals in Real-world Clinical Settings: Results From 2 Large HIV Care Clinics. Clin Infect Dis. 2016 10 01; 63(7):994-5.
    View in: PubMed
    Score: 0.010
  49. Castillo-Mancilla JR, Zheng JH, Rower JE, Meditz A, Gardner EM, Predhomme J, Fernandez C, Langness J, Kiser JJ, Bushman LR, Anderson PL. Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure. AIDS Res Hum Retroviruses. 2013 Feb; 29(2):384-90.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)